Frequent Amplification and Overexpression of PSMA in Basallike Breast Cancer from Analysis of The Cancer Genome Atlas.

basallike breast cancer cancer genome genomic alteration prostate-specific membrane antigen

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
25 Apr 2024
Historique:
received: 14 09 2023
revised: 26 02 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 25 4 2024
Statut: aheadofprint

Résumé

Prostate-specific membrane antigen (PSMA) is frequently overexpressed in nonprostate malignancies. This preclinical study investigated the molecular basis of the application of PMSA-targeting radiopharmaceuticals in breast cancer subtypes.

Identifiants

pubmed: 38664014
pii: jnumed.123.266659
doi: 10.2967/jnumed.123.266659
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Wenhui Zhou (W)

Department of Radiology, Stanford University Medical Center, Stanford, California; wzhou02@stanford.edu.

Sumit Halder (S)

iNDX.AI, Cupertino, California; and.

Sanna Herwald (S)

Department of Radiology, Stanford University Medical Center, Stanford, California.

Michael Ghijsen (M)

Department of Radiology, Stanford University Medical Center, Stanford, California.

Gowhar Shafi (G)

iNDX.AI, Cupertino, California; and.

Mohan Uttarwar (M)

iNDX.AI, Cupertino, California; and.

Eric Rosen (E)

Department of Radiology, Stanford University Medical Center, Stanford, California.

Benjamin Franc (B)

Department of Radiology, Stanford University Medical Center, Stanford, California.

Sirish Kishore (S)

Department of Radiology, Stanford University Medical Center, Stanford, California.
Department of Radiology, Palo Alto Veterans Affairs Healthcare System, Palo Alto, California.

Classifications MeSH